HS-10390

DRUG2 trials

Sponsors

Hansoh BioMedical R&D Company, Jiangsu Hansoh Pharmaceutical Co., Ltd.

Conditions

Chronic Kidney DiseaseImmunoglobulin a Nephropathy

Phase 2

A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy

Not yet recruitingNCT06635772

Hansoh BioMedical R&D CompanyImmunoglobulin a Nephropathy

Start: 2024-11-30End: 2026-04-30Target: 90Updated: 2024-10-10

A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease

Not yet recruitingNCT07555054

Jiangsu Hansoh Pharmaceutical Co., Ltd.Chronic Kidney Disease

Start: 2026-05-21End: 2028-12-31Target: 182Updated: 2026-04-28